Atlas Venture Opportunity Fund I, L.p. - Net Worth and Insider Trading

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made 1 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 46,534. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 244,099 shares made by Jonathan Mcneill , a net sale of 194,534 shares made by Richard William Scalzo , and a net sale of 133,322 shares made by Oxana Beskrovnaya .

In summary, during the past 3 months, insiders sold 921,534 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 921,534 shares. During the past 18 months, 5,516,515 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,933,068 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 989,618 shares made by Bruce Booth , a net sale of 862,075 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .

In summary, during the past 3 months, insiders sold 844,110 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 844,110 shares. During the past 18 months, 1,927,748 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 1,472,636 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 343,870 shares made by Andrew Cheng , a net sale of 69,475 shares made by Jonathan Young , and a net sale of 77,268 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 110,332 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 110,332 shares. During the past 18 months, 2,361,483 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net sale of 1,041,483 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 41,467 shares made by Sushil Patel , and a net sale of 14,451 shares made by Konstantinos Xynos .

In summary, during the past 3 months, insiders sold 98,084 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 98,084 shares. During the past 18 months, 272,276 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 272,276 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 766,635 shares, with a net purchase of 766,635 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 766,635 shares were bought by its insiders, resulting in a net purchase of 766,635 shares.

Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,918 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,918 shares. During the past 18 months, 3,899,867 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,692 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Vigil Neuroscience Inc (VIGL). Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net purchase of 4,000 shares made by Ivana Magovcevic-liebisch ,

In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vigil Neuroscience Inc (VIGL) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 4,000 shares.

Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ikena Oncology Inc (IKNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ikena Oncology Inc (IKNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ikena Oncology Inc (IKNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 128,497 shares made by Samuel C. Blackman , a net sale of 144,428 shares made by Jeremy Bender , and a net sale of 98,942 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 215,740 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 215,740 shares. During the past 18 months, 473,033 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,771,651 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Atlas Venture Opportunity Fund I, L.p. made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,780 shares made by Natalie C. Holles , a net sale of 24,620 shares made by , and a net sale of 13,970 shares made by Julie Person .

In summary, during the past 3 months, insiders sold 59,507 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 59,507 shares. During the past 18 months, 77,160 shares of Third Harmonic Bio Inc (THRD) were sold and 214,063 shares were bought by its insiders, resulting in a net purchase of 136,903 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.